UPS: Ultrasound Study in Pregnant Women With Malaria
Study Details
Study Description
Brief Summary
Most of the neonatal deaths that occur worldwide every year are associated with low birth weight (LBW), caused by intrauterine growth restriction (IUGR) and/or preterm delivery. Accurate assessment of fetal growth and gestational age for timely identification and management of growth restriction are therefore public health priorities, especially in developing countries where 98% of all neonatal deaths occur. Every year, more than 50 million women become pregnant in malaria endemic regions. Malaria infection at any time during pregnancy reduces birthweight. However, little is known about the relationship between the timing of infection during pregnancy and the extent of the impact on birth weight. The mechanisms by which malaria causes LBW also remain unclear. Reduced placental blood flow, placental changes, red blood cell changes, severe anaemia and pro-inflammatory cytokines have all been implicated.
In this proposed, longitudinal, observational, minimal risk study, which will take place in SMRU antenatal clinics on the Thai-Burmese border, the effect of malaria infection during pregnancy on fetal growth will be determined. Women will be screened before 13+6 weeks of gestation and followed with regular ultrasound examinations during pregnancy. When a woman has a malaria infection an extra ultrasound scan will be done to measure growth retardation or placental blood flow changes. Bloodsamples will be taken to detect changes in red blood cell properties and putative markers of malaria infection. For this study the maximum amount of blood taken during pregnancy is 13 cc in an uninfected woman. For each malaria episode an additional 7 cc blood will be taken. After delivery a placenta and a cord sample will be taken to detect placental changes. The investigators aim to recruit four hundred pregnant women over the course of two years. This study involves minimal risk to participants as ultrasound examination is part of routine antenatal care in many countries in the world.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Pregnant women Pregnant women who present at the SMRU antenatal clinics on the Thai Burmese border. |
Outcome Measures
Primary Outcome Measures
- Ultrasound measurements [Up to birth]
Secondary Outcome Measures
- Examination of all newborns [6 months post natal]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Singleton viable pregnancy. If not detected at enrolment, multiple pregnancies will be excluded from the analysis.
-
Age ≥18 years old.
-
Willing and able to participate and comply with the study protocol and attend the SMRU ANCs regularly.
-
EGA between 9+0 and 13+6 weeks by Ultrasound (CRL)
-
Able to communicate in Burmese, Karen or English language
-
written informed consent to participate in trial and follow consultation
Exclusion Criteria:
-
Evidence of major congenital abnormality in the present pregnancy (e.g. anencephaly, omphalocele, hydrocephalus).
-
Known chronic maternal illness.
-
Thai national whose primary language is Thai
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Shoklo Malaria Research Unit | Mae Sot | Tak | Thailand | 63110 |
Sponsors and Collaborators
- University of Oxford
Investigators
- Principal Investigator: Francois Nosten, MD, Shoklo Malaria Research Unit
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SMRU0801